SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-19-008312
Filing Date
2019-12-26
Accepted
2019-12-26 08:01:30
Documents
14
Period of Report
2019-12-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_122419.htm   iXBRL 8-K 14294
2 PRESS RELEASE exh_991.htm EX-99.1 8074
  Complete submission text file 0001171843-19-008312.txt   228134

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3095
4 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25969
5 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 35566
6 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 24600
13 EXTRACTED XBRL INSTANCE DOCUMENT f8k_122419_htm.xml XML 3023
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

IRS No.: 611009366 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12104 | Film No.: 191308372
SIC: 2835 In Vitro & In Vivo Diagnostic Substances